Published in Immunology on February 01, 1995
Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin Exp Immunol (1998) 1.27
Fundal white dots: the spectrum of a similar pathological process. Br J Ophthalmol (1995) 1.20
Interleukin and growth factor levels in subretinal fluid in rhegmatogenous retinal detachment: a case-control study. PLoS One (2011) 1.04
Sub-lytic C5b-9 induces functional changes in retinal pigment epithelial cells consistent with age-related macular degeneration. Eye (Lond) (2011) 1.04
Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. Mol Vis (2009) 1.00
Intravitreal invading cells contribute to vitreal cytokine milieu in proliferative vitreoretinopathy. Br J Ophthalmol (2001) 1.00
Mechanisms of epithelial wound detection. Trends Cell Biol (2015) 0.96
Bacillus cereus-induced permeability of the blood-ocular barrier during experimental endophthalmitis. Invest Ophthalmol Vis Sci (2009) 0.95
Cytokine regulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production by human retinal pigment epithelial cells. Clin Exp Immunol (1999) 0.85
Enhanced PKCδ and ERK signaling mediate cell migration of retinal pigment epithelial cells synergistically induced by HGF and EGF. PLoS One (2012) 0.81
Interleukin-6 receptor blockade suppresses subretinal fibrosis in a mouse model. Int J Ophthalmol (2014) 0.76
Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration? Autoimmun Rev (2017) 0.76
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science (1989) 6.89
Biology of multifunctional cytokines: IL 6 and related molecules (IL 1 and TNF). FASEB J (1990) 5.16
Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature (1990) 3.81
Inflammatory and immunomodulatory roles of TGF-beta. Immunol Today (1989) 2.56
Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest Ophthalmol Vis Sci (1991) 2.37
Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol (1990) 2.25
Growth characteristics and ultrastructure of human retinal pigment epithelium in vitro. Invest Ophthalmol Vis Sci (1980) 1.42
Interleukin-1 beta and tumor necrosis factor-alpha induce gene expression and production of leukocyte chemotactic factors, colony-stimulating factors, and interleukin-6 in human mesangial cells. Am J Pathol (1991) 1.41
Transforming growth factor-beta and IL-1 beta act in synergy to enhance IL-6 secretion by the intestinal epithelial cell line, IEC-6. J Immunol (1993) 1.27
Glial retinal Müller cells produce IL-1 activity and have a dual effect on autoimmune T helper lymphocytes. Antigen presentation manifested after removal of suppressive activity. J Immunol (1988) 1.22
Cytokines and uveitis, a review. Curr Eye Res (1992) 1.21
Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood (1990) 1.13
Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes. Curr Eye Res (1992) 1.06
Transforming growth factor-beta regulation of IL-6 production by unstimulated and IL-1-stimulated human fibroblasts. J Immunol (1991) 1.06
Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet (1988) 1.05
Pathologic concentrations of interleukin 6 inhibit T cell responses via induction of activation of TGF-beta. FASEB J (1991) 1.04
Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest Ophthalmol Vis Sci (1991) 1.03
Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1. Invest Ophthalmol Vis Sci (1992) 1.02
Activity of an interleukin 1 receptor antagonist in rabbit models of uveitis. Arch Ophthalmol (1992) 1.00
Analysis of interleukin-6 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (1991) 0.98
Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp Eye Res (1992) 0.96
Transforming growth factor-beta mediates IL-1-dependent induction of IL-1 receptor antagonist. J Immunol (1993) 0.92
Cytokines and intraocular inflammation. Curr Eye Res (1990) 0.86
Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol (2000) 2.10
Clinical investigation of a true color scanning laser ophthalmoscope. Arch Ophthalmol (2001) 2.07
A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med (2003) 1.72
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology (1980) 1.67
Orientation and directed migration of cultured corneal epithelial cells in small electric fields are serum dependent. J Cell Sci (1996) 1.58
The corneoscleral limbus in human corneal epithelial wound healing. Am J Ophthalmol (1990) 1.54
Urokinase in the treatment of vitreous haemorrhage. Lancet (1972) 1.51
An image-processing strategy for the segmentation and quantification of microaneurysms in fluorescein angiograms of the ocular fundus. Comput Biomed Res (1996) 1.47
Quantitative image analysis of macular drusen from fundus photographs and scanning laser ophthalmoscope images. Eye (Lond) (1995) 1.45
Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis? Eye (Lond) (1997) 1.41
Cell subpopulations in failed human corneal grafts. Br J Ophthalmol (1999) 1.41
Quantification of diabetic maculopathy by digital imaging of the fundus. Eye (Lond) (1991) 1.40
Sympathetic ophthalmia risk following vitrectomy: should we counsel patients? Br J Ophthalmol (2000) 1.38
Adhesion of neutrophil leucocytes under conditions of flow. J Cell Sci (1984) 1.35
Clinical investigation of an infrared digital scanning laser ophthalmoscope. Br J Ophthalmol (1994) 1.35
A small, physiological electric field orients cell division. Proc Natl Acad Sci U S A (1999) 1.34
Electric field-directed cell motility involves up-regulated expression and asymmetric redistribution of the epidermal growth factor receptors and is enhanced by fibronectin and laminin. Mol Biol Cell (1999) 1.29
Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina. Eur J Immunol (1996) 1.27
Directed migration of corneal epithelial sheets in physiological electric fields. Invest Ophthalmol Vis Sci (1996) 1.23
Adhesion of cells to polystyrene surfaces. J Cell Biol (1983) 1.21
Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uveoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol (1993) 1.21
Fundal white dots: the spectrum of a similar pathological process. Br J Ophthalmol (1995) 1.20
Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol (2002) 1.20
Ultrastructural pathology of S-antigen uveoretinitis. Invest Ophthalmol Vis Sci (1985) 1.17
Immunosuppressive treatment of choroidal neovascularization associated with endogenous posterior uveitis. Arch Ophthalmol (1998) 1.17
Human corneal epithelial cells reorient and migrate cathodally in a small applied electric field. Curr Eye Res (1997) 1.17
Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia (1997) 1.17
Clinical patterns of corneal epithelial wound healing. Am J Ophthalmol (1987) 1.17
A comparison of computer based classification methods applied to the detection of microaneurysms in ophthalmic fluorescein angiograms. Comput Biol Med (1998) 1.16
Digital fundus imaging using a scanning laser ophthalmoscope. Physiol Meas (1993) 1.16
Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology (1990) 1.15
Expression of the chemokines MIP-1alpha, MCP-1, and RANTES in experimental autoimmune uveitis. Invest Ophthalmol Vis Sci (2001) 1.14
Campath-1H therapy in refractory ocular inflammatory disease. Br J Ophthalmol (2000) 1.13
Automated detection and quantification of microaneurysms in fluorescein angiograms. Graefes Arch Clin Exp Ophthalmol (1992) 1.13
Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest Ophthalmol Vis Sci (1999) 1.13
Automated detection of microaneurysms in digital red-free photographs: a diabetic retinopathy screening tool. Diabet Med (2000) 1.13
A fully automated comparative microaneurysm digital detection system. Eye (Lond) (1997) 1.12
The scanning laser ophthalmoscope--a review of its role in bioscience and medicine. Phys Med Biol (2004) 1.12
Inhibition of leukocyte locomotion by hyaluronic acid. J Cell Sci (1981) 1.11
Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunology (1994) 1.10
Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c+CD4low parenchymal microglia. Br J Ophthalmol (1995) 1.09
Nitric oxide accelerates the onset and increases the severity of experimental autoimmune uveoretinitis through an IFN-gamma-dependent mechanism. J Immunol (1997) 1.09
Rescue therapy with mycophenolate mofetil in refractory uveitis. Lancet (1998) 1.09
Clinical experience with interferon alfa-2a for exudative age-related macular degeneration. Br J Ophthalmol (1993) 1.08
Immunosuppressive therapy for chronic uveitis: optimising therapy with steroids and cyclosporin A. Br J Ophthalmol (1997) 1.08
Histology of the lacrimal gland in keratoconjunctivitis sicca. Br J Ophthalmol (1973) 1.07
Retinal antigen specific lymphocytes, TCR-gamma delta T cells and CD5+ B cells cultured from the vitreous in acute sympathetic ophthalmitis. Autoimmunity (1993) 1.07
Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin Exp Immunol (1988) 1.06
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H. Br J Ophthalmol (1995) 1.06
Immunomodulation of experimental autoimmune uveoretinitis: a model of tolerance induction with retinal antigens. Eye (Lond) (1994) 1.04
Cyclosporin A therapy in refractory non-infectious childhood uveitis. Br J Ophthalmol (1998) 1.04
Chemokinetic accumulation of human neutrophils on immune complex-coated substrata: analysis at a boundary. J Cell Biol (1984) 1.02
Elevated plasma CD105 and vitreous VEGF levels in diabetic retinopathy. J Cell Mol Med (2005) 1.02
Fundus autofluorescence in the diagnosis of cystoid macular oedema. Br J Ophthalmol (2008) 1.02
Fundus imaging in patients with cataract: role for a variable wavelength scanning laser ophthalmoscope. Br J Ophthalmol (1995) 1.01
Distribution of OX2 antigen and OX2 receptor within retina. Invest Ophthalmol Vis Sci (2001) 1.00
Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol (2001) 1.00
Lytic therapy in vitreous haemorrhage. Trans Ophthalmol Soc U K (1974) 1.00
CXCR4 receptor expression on human retinal pigment epithelial cells from the blood-retina barrier leads to chemokine secretion and migration in response to stromal cell-derived factor 1 alpha. J Immunol (2000) 1.00
Intravitreal fibrinolysis in experimental vitreous haemorrhage. Exp Eye Res (1976) 0.99
Combination low dose cyclosporin A and steroid therapy in chronic intraocular inflammation. Eye (Lond) (1990) 0.99
Performance measurements of an infrared digital scanning laser ophthalmoscope. Physiol Meas (1994) 0.98
Properties of porcine and recombinant human collagen matrices for optically clear tissue engineering applications. Biomacromolecules (2006) 0.98
Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell Immunol (1998) 0.97
Control of chemokine production at the blood-retina barrier. Immunology (2000) 0.97
Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Cell Immunol (1993) 0.97
Management of the dry eye in Sjogren's syndrome. Br J Ophthalmol (1974) 0.96
Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol (2000) 0.96
Nuclear magnetic resonance tomography of the orbit at 3.4 MHz. Br J Radiol (1985) 0.96
Tacrolimus (FK506) in failed cyclosporin A therapy in endogenous posterior uveitis. Ocul Immunol Inflamm (1998) 0.95
Imaging of optic nerve head drusen with the scanning laser ophthalmoscope. Br J Ophthalmol (1997) 0.95
The value of digital imaging in diabetic retinopathy. Health Technol Assess (2003) 0.95
Steroid induced glaucoma: a report of two cases with a review of morbidity and prescribing in general practice. Scott Med J (1990) 0.95
The prevalence of sight-threatening uveitis in Scotland. Br J Ophthalmol (2006) 0.93
Retinal capillary endothelial cells prefer different substrates for growth and migration. Tissue Cell (1988) 0.93
IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice. Invest Ophthalmol Vis Sci (2001) 0.92
A simplified method for the isolation of highly purified bovine retinal S antigen. J Neuroimmunol (1987) 0.92
Low-dose cyclosporin therapy of ocular inflammation: preliminary report of a long-term follow-up study. J Autoimmun (1992) 0.91
EAU in the guinea pig: inhibition of cell-mediated immunity and Ia antigen expression by cyclosporin A. Clin Exp Immunol (1987) 0.91
The preprocessing of retinal images for the detection of fluorescein leakage. Phys Med Biol (1999) 0.91
Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol (2005) 0.91
Ophthalmopathy in early thyrotoxicosis--relationship to thyroid receptor antibodies and effects of treatment. Scott Med J (1990) 0.91
EB-virus transformed human lymphocytes from uveitis and retinitis pigmentosa patients secrete antibodies to retinal antigens. J Clin Lab Immunol (1988) 0.90
CD69 expression on peripheral CD4+ T cells parallels disease activity and is reduced by mycophenolate mofetil therapy in uveitis. Invest Ophthalmol Vis Sci (2001) 0.90
Immunocytochemical analysis of blood lymphocytes in uveitis. Eye (Lond) (1992) 0.90
Endotoxin-induced uveitis in the rat. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1980) 0.90
Macrophages eyed in macular degeneration. Nat Med (2003) 0.90
Resolution of juvenile idiopathic arthritis-associated uveitis after development of common variable immunodeficiency. Eur J Ophthalmol (2007) 0.90
Corneal epithelial cell migration in humans: 'hurricane and blizzard keratopathy'. Eye (Lond) (1993) 0.90
Regulation of glucose transporter (GLUT 3) and aldose reductase mRNA inbovine retinal endothelial cells and retinal pericytes in high glucose and high galactose culture. Diabetologia (1993) 0.90
The effect of retinal S-antigen-specific monoclonal antibody therapy on experimental autoimmune uveoretinitis (EAU) and experimental autoimmune pinealitis (EAP). Clin Exp Immunol (1989) 0.90
Cyclosporine-induced resolution of choroidal neovascularization associated with sympathetic ophthalmia. Arch Ophthalmol (1998) 0.89
Vitreous membrane formation after experimental vitreous haemorrhage. Albrecht Von Graefes Arch Klin Exp Ophthalmol (1980) 0.89
Ultrastructural pathology of the 'barrier sites' in experimental autoimmune uveitis and experimental autoimmune pinealitis. Br J Ophthalmol (1991) 0.89
Low dose cyclosporin A therapy in chronic posterior uveitis. Eye (Lond) (1989) 0.89